Kanika Bahl
Kanika Bahl is CEO and president of Evidence Action, an NGO that scales low-cost health interventions to improve the well-being of hundreds of millions of people in Africa and Asia. She is also on the board of TechnoServe and a trustee of Anthropic’s Long-Term Benefit Trust. Previously she served as managing director at Results for Development, or R4D, where she established and led the market dynamics practice. Prior to R4D, Kanika served as an executive vice president at the Clinton Health Access Initiative.
Latest Articles
Opinion: Courage over convention — new ideas to get the SDGs on track
over 2 years ago // Sponsored by Evidence Action
After a decade of creative health and development approaches benefitting over 500 million people, Evidence Action’s CEO shares lessons on being bolder to maximize impact and close the SDG gap.
Using markets to improve children’s lives
over 10 years ago // #innov8aid
There's a cheap, effective treatment to childhood pneumonia, yet nearly 1 million still die from the disease each year. The problem is access, and here's how that can be addressed.